Patent: 9,247,960
✉ Email this page to a colleague
Summary for Patent: 9,247,960
| Title: | Recovery and processing of human embryos formed in vivo |
| Abstract: | Among other things, uterine lavage is performed to withdraw at least 50% of in vivo fertilized preimplantation embryos produced after superovulation of a woman and artificial insemination using sperm of her sexual partner. After genetic diagnosis or sex determination or gene therapy, or any combination of any two or more of them, of the recovered embryos and selection of at least one of the embryos to be implanted, the selected embryos are returned to the woman for implantation in her uterus. |
| Inventor(s): | Carson; Sandra Ann (Providence, RI), Buster; John E. (Providence, RI) |
| Assignee: | Previvo Genetics, LLC (Piedmont, CA) |
| Application Number: | 14/250,240 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,247,960 |
| Patent Claims: | see list of patent claims |
Details for Patent 9,247,960
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 08/22/1975 | ⤷ Try a Trial | 2031-12-22 |
| Emd Serono, Inc. | PERGONAL | menotropins | For Injection | 017646 | 05/20/1985 | ⤷ Try a Trial | 2031-12-22 |
| Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | HUMEGON | menotropins | For Injection | 020328 | 09/01/1994 | ⤷ Try a Trial | 2031-12-22 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
